PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS

Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.
Famar explains how it will continue develop capabilities so as to accompany its customers through clinical phases with clinical batches, scale-up, and ultimately manufacturing and packaging.
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.

PHARMA & LIFE SCIENCES: LATEST ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

Turkey Pharmaceuticals: Bringing All Actors Together

June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Pharmaceuticals & Biopharmaceuticals 2021

PARTNER EVENTS